US sharemarkets were weaker in a volatile session on Wednesday, driven by news of the first case of Omicron to be found in the US (California). The Cboe volatility gauge (Vix) rose 11% to 9-month highs. Shares in Merck fell 0.6% despite positive regulatory news on its pill to treat Covid-19. At the close of trade the Dow Jones index was lower by 462 points or 1.3% after being up 521 points earlier in the session. The S&P 500 index fell by 1.2%. The Nasdaq index fell by 284 points or 1.8%.
European sharemarkets posted the strongest sessions in around six months on Wednesday. Autos rose by 3.8% and travel & leisure rose by 3.1%. Materials rose 2.3% and energy rose 2.1%. Restraining sentiment was data showing factory price inflation at the fastest rate in 19 years. The pan-European STOXX 600 index rose by 1.7%. The German Dax index rose by 2.5%. And the UK FTSE index lifted by 1.6%. In London trade, shares in Rio Tinto rose by 1.7%; BHP shares rose 0.4%.
This report is approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399 AFSL 238814 (CommSec) a wholly owned but non-guaranteed subsidiary of the Commonwealth Bank of Australia ABN 48 123 123 124 AFSL 234945 (the Bank), and a market participant of ASX Limited and CHI-X Pty Limited, a clearing participant of ASX Clear Pty Limited and a settlement participant of ASX Settlement Pty Limited. Any advice contained in this report is general advice only and is not a recommendation to buy, sell or hold any securities, property, real estate or financial products, and has been prepared without taking account of the objectives, financial or taxation situation or needs of any particular individual. Before making any investment decision, you should consider your own investment needs and objectives and consider seeking financial advice. Past performance is not a reliable indicator of future performance. This report is produced by Commonwealth Securities Limited based on information available at the time of publishing. We believe that the information in this report is correct and any opinions, conclusions or recommendations are reasonably held or made as at the time of its compilation, but no warranty is made as to accuracy, reliability or completeness. To the extent permitted by law, neither the Bank nor any of its subsidiaries accept liability to any person for loss or damage arising from the use of this report.
Market Close 16 Feb 23: ASX 200 bounces back from 4-week low
CommSec Insights 16 Feb 23: The Week Ahead
The CommSec Market Update 16 Feb 23: US shares mixed after retail sales data prints stronger than expected
Market Close 15 Feb 23: ASX 200 hits 4-week low
Fortescue’s Half Year Result 15 Feb 23: Payout ratio creeps lower
The CommSec Market Update 15 Feb 23: Volatile reaction by financial markets to latest US inflation data
Market Close 14 Feb 23: ASX 200 snaps 3-day losing streak
CSL’s Half Year Result 14 Feb 23: Plasma collections hit record high
The CommSec Market Update 14 Feb 23: US stocks advance ahead of key inflation data
Market Close 13 Feb 23: ASX 200 slides for 3rd day
Morning Report 13 Feb 23: ASX set for a flat start
Market Close 10 Feb 23: ASX 200’s 5-week winning streak ends
The CommSec Market Update 10 Feb 23: Google parent Alphabet weighs on Wall Street. German inflation eases
Market Close 9 Feb 23: ASX 200 slips for 3rd time in 4 days
Executive Series 25 Jan 23: PM Capital Co-Portfolio Manager – Equities, Kevin Bertoli Part 2
CommSec Insights 9 Feb 23: The Week Ahead
Morning Report 9 Feb 22: Wall St retreats led by technology
Market Close 8 Feb 23: ASX 200’s first gain of the week
Executive Series 25 Jan 23: PM Capital Co-Portfolio Manager, Equities, Kevin Bertoli Part 1
Reporting Season Preview 6 Feb 23: Cost control and outlooks in focus
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
U.S Property Podcast
Aligned Money Show
Dubai Property Podcast
The Ramsey Show
The Clark Howard Podcast